Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Inotek Pharmaceuticals revenue
Inotek Pharmaceuticals's revenue is $1.0 million.
What is Inotek Pharmaceuticals's revenue?
- Inotek Pharmaceuticals peak revenue was $1.0M in 2024.
- Inotek Pharmaceuticals has 91 employees, and the revenue per employee ratio is $10,989.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Inotek Pharmaceuticals financing
Inotek Pharmaceuticals received early financing of $20.0M on 2004-04-14.
| Series | Round size | Date |
|---|---|---|
| Series A | $20M | 04/2004 |
| Series B | $35M | 11/2005 |
| Series C | $19.3M | 08/2007 |
| Series D | $23.6M | 07/2011 |
| Debt Financing | $7M | 09/2013 |
| Series Unknown | $21M | 09/2013 |
Inotek Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Rho Ventures | Series A |
| MedImmune Ventures Inc | Series A |
| Care Capital LLC | Series A |
| Caisse de dépôt et placement du Québec CDPQ | Series B |
| Rho Ventures | Series B |
| MedImmune Ventures Inc | Series B |
| Care Capital LLC | Series B |
| Pitango | Series B |
| Caisse de dépôt et placement du Québec CDPQ | Series C |
| Rho Ventures | Series C |
| MedImmune Ventures Inc | Series C |
| Care Capital LLC | Series C |
| Pitango | Series C |
| MedImmune Ventures Inc | Series D |
| DEVON PARK BIOVENTURES | Series D |
| Rho Ventures | Series D |
| Care Capital LLC | Series D |
| Pitango | Series D |
| Rho Ventures | Debt Financing |
| MedImmune Ventures Inc | Debt Financing |
| DEVON PARK BIOVENTURES | Debt Financing |
| Care Capital LLC | Debt Financing |
| Pitango | Debt Financing |
| Horizon Technology Finance | Debt Financing |
| Rho Ventures | Series Unknown |
| MedImmune Ventures Inc | Series Unknown |
| DEVON PARK BIOVENTURES | Series Unknown |
| Care Capital LLC | Series Unknown |
| Pitango | Series Unknown |
Inotek Pharmaceuticals competitors
Inotek Pharmaceuticals's top competitor, AMRI, earned an annual revenue of $276.6M.
Inotek Pharmaceuticals's smallest competitor is Frontage Laboratories with revenue of $560.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cardioxyl Pharmaceuticals | $66,119 | $1.4M | 30 | - |
| Adverum Biotechnologies | $90,460 | $3.6M | 188 | 1 |
| Imago BioSciences | $52,336 | $108.8M | 14 | - |
| Tergus Pharma | $77,359 | $11.6M | 116 | - |
| Aradigm | $68,338 | $14.5M | 23 | - |
| Hi-Tech Pharmacal | $64,715 | $232.4M | 200 | - |
| AMRI | $76,714 | $276.6M | 3,085 | - |
| Ricerca Biosciences | $76,083 | $14.0M | 200 | 10 |
| Frontage Laboratories | $66,952 | $560,000 | 50 | 136 |
| Xenobiotic Laboratories, Inc., A Wholly Owned Subsidiary Of Wuxi... | $77,924 | $18.0M | 150 | - |
Inotek Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Inotek Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Inotek Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Inotek Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Inotek Pharmaceuticals. The data presented on this page does not represent the view of Inotek Pharmaceuticals and its employees or that of Zippia.
Inotek Pharmaceuticals may also be known as or be related to INOTEK PHARMACEUTICALS CORP, Inotek Pharmaceuticals, Inotek Pharmaceuticals Corp. and Inotek Pharmaceuticals Corporation.